04.22.25 -- How AI Is A Game-Changer For Auditing Compliance And Efficiency

While moving from early- to late-phase clinical trials is a critical milestone to celebrate on the way to commercialization, many face the same daunting question once the confetti settles ― now what?

Drug shortages have increased the burden on compounding pharmacies. Robotics and automation can streamline processes, improve accuracy, and ensure quality to address these challenges.

Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

Watch as experts walk through several technologies and case studies that focus on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

Industry 4.0 drives life sciences to prioritize data-driven decision-making by integrating advanced technologies in QMS. Discover how modern data management can improve compliance.

Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

Challenges specific to eye physiology complicate the development of new therapies and necessitate innovative drug delivery. Biodegradable polymers show promise in addressing these challenges.

Examine three case studies that show how direct water activity measurements can determine the impact of moisture on potency and dissolution.

The first step towards IT-OT collaboration is getting these functions to speak the same language. Here, we outline key Industrial DataOps terms and aim to establish a common dictionary for IT and OT.

A new algorithm developed by a real-time viable particle counter determines the viability of a particle based on its measured optical properties to improve the detection of microorganisms.

Gain insight into the critical role plunger stoppers play in determining a combination drug product's exposure to extractables and leachables.

Explore the advantages offered by an orally dissolving tablet platform relating to large molecule storage, aggregation, and, in some cases, protease activity.

In silico and in vitro design and optimization serve as valuable tools in early assessments by identifying and mitigating risks as well as improving developability of the candidate molecule.